Kyorin Pharmaceutical and Yissum enter respiratory drug development collaboration Dec. 28, 2018 No Comments
HAL Allergy begins first-in-human study of HAL-MRE1 in ragweed allergic patients Dec. 20, 2018 No Comments
Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment Dec. 7, 2018 No Comments
Faron identifies optimal subgroup of patients for Traumakine treatment in INTEREST study Dec. 5, 2018 No Comments
aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis Dec. 5, 2018 No Comments
RSS